MB "Fibroblastai" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
13,600 |
10,968 |
1,781 |
1,689 |
1,362 |
100.00 |
12.42 |
4,777 |
835 |
6,252 |
5,612 |
2023 |
---|
22,350 |
11,175 |
1,428 |
1,356 |
678 |
99.93 |
6.07 |
6,133 |
598 |
3,254 |
6,731 |
2024 |
---|
29,600 |
14,369 |
12,135 |
11,527 |
5,596 |
99.79 |
38.94 |
17,660 |
2,237 |
255 |
19,897 |
Register and
explore Okredo data2024 |
---|
29,600 |
14,369 |
12,135 |
11,527 |
5,596 |
99.79 |
38.94 |
17,660 |
2,237 |
255 |
19,897 |
Register and
explore Okredo data2024
Turnover (€)
29,600 €32 % *
Sales per employee (€)
14,369 €29 % *
Profit before tax (€)
12,135 €750 % *
Net Profit (€)
11,527 €750 % *
Profit per employee (€)
5,596 €725 % *
Total profitability (%)
99.79 %-0.14 % *
Net profitability (%)
38.94 %541.52 % *
Equity (€)
17,660 €188 % *
Amounts Payable And Liabilities (€)
2,237 €274 % *
Non-current Assets (€)
255 €-92 % *
CurrentAssets (€)
19,897 €196 % *